Antimicrobial Susceptibility Test Market Is Anticipated to Reach US$ 5,712.2 Million by 2032

The global antimicrobial susceptibility test market is set to enjoy a valuation of US$ 3,285.8 Million in 2022 and further expand at a CAGR of 5.7% to reach US$ 5,712.2 Million by the end of 2032. Kits, Reagents & Consumables segment leads the antimicrobial susceptibility test market and is expected to contribute more than 58% of the global market growth over the assessment period.

The offer in this portion accompanies many open doors including fabricating items, appropriation, retail, and showcasing administrations. Broad rounds of essential and far reaching optional exploration have been utilized by the examiners at Fact.MR to show up at different assessments and projections for Demand of Antimicrobial Susceptibility Test Market both at worldwide and provincial levels.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: -https://www.factmr.com/connectus/sample?flag=S&rep_id=4334?PJ

The global antimicrobial susceptibility test market is marked by continuous growth due to several key factors. The increasing prevalence of bacterial infections, the emergence of antibiotic-resistant strains, and the need for personalized medicine are driving the demand for AST. In healthcare settings, accurate and timely susceptibility testing is crucial to ensure patients receive the most effective antibiotic treatment, which, in turn, is essential for reducing the spread of drug-resistant bacteria and improving patient outcomes.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: -

Bio-Rad Laboratories, Inc.
Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
Conda
Creative Diagnostics
HiMedia Laboratories
Alifax Holding S.p.A.
Biotron Healthcare

"𝗥𝗶𝘀𝗶𝗻𝗴 𝗠𝗶𝗰𝗿𝗼𝗯𝗶𝗮𝗹 𝗥𝗲𝘀𝗶𝘀𝘁𝗮𝗻𝗰𝗲 𝘁𝗼 𝗗𝗿𝗶𝘃𝗲 𝘁𝗵𝗲 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗔𝗻𝘁𝗶𝗺𝗶𝗰𝗿𝗼𝗯𝗶𝗮𝗹 𝗦𝘂𝘀𝗰𝗲𝗽𝘁𝗶𝗯𝗶𝗹𝗶𝘁𝘆 𝗧𝗲𝘀𝘁𝘀"

Antimicrobial susceptibility testing is becoming more and more popular as a result of rising microbial resistance, which is boosting the size of the global market. People of all ages and races are impacted by the complex issue of antimicrobial resistance.

According to Fact.MR data, antimicrobial resistance causes approximately 2 million infections and 23,000 fatalities annually in the United States, as well as an estimated 25,000 deaths from antibacterial-resistant diseases in Europe. Thus, there is a growing need for novel broad spectrum antibacterial medications.

Additionally, government funding and attention are two more important factors influencing the development of the target product. For instance, the WHO and other non-profit funding organisations proposed a new antimicrobial innovation funding mechanism, in which the government would finance grants and innovation-induced rewards that would benefit upstream innovation, interim trial findings, as well as the outcomes of the finished product.

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲

Prominent Antimicrobial susceptibility test manufacturers are Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Conda, Creative Diagnostics, HiMedia Laboratories, Alifax Holding S.p.A., Biotron Healthcare.

The leading companies in the global antimicrobial susceptibility test market are involved in product launches, regulatory approvals, technologically enhanced products, acquisitions, and joint ventures with other enterprises. These strategies are probably going to boost the global market for antibiotic susceptibility tests.

In Apr 2022, bioMérieux acquire specific diagnostics. This will help the company to strengthen its commitment to fight antimicrobial resistance.
In Aug 2022, BD, a leading global medical technology company, announced worldwide commercial collaboration with Accelerate Diagnostics, Inc. which will help both the companies to address the global threat of antimicrobial resistance.

𝗥𝗲𝗰𝗲𝗻𝘁 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗡𝗲𝘄𝘀:

Emergence of Superbugs: Recent news highlights the alarming rise of superbugs-bacterial strains that are resistant to multiple antibiotics. This trend underscores the critical role of AST in identifying effective treatment options and preventing the spread of drug-resistant infections. News reports often feature cases of superbugs in healthcare facilities, which highlight the importance of rapid and accurate susceptibility testing.

Technological Advancements: Advances in technology are transforming the AST landscape. News articles emphasize the development of automated and high-throughput susceptibility testing systems, which improve testing accuracy and efficiency. These innovations are poised to streamline clinical workflows and provide more rapid results.

Precision Medicine Approach: Personalized medicine is a growing trend in healthcare, and AST plays a crucial role in tailoring antibiotic therapy to individual patients. Recent industry news showcases the use of genotypic and phenotypic AST methods to guide antibiotic selection, minimizing the risk of treatment failure and adverse effects.

Rising Cases of Healthcare-Associated Infections: Healthcare-associated infections (HAIs) remain a significant concern, and news reports frequently highlight outbreaks in healthcare facilities. AST is instrumental in identifying and managing HAIs, reducing their impact on patient safety and hospital operations.

Global Health Threats: Infectious diseases, including bacterial infections, continue to pose global health threats. Recent news reports on outbreaks and pandemics, such as the COVID-19 pandemic, underscore the need for rapid and reliable susceptibility testing to respond effectively to infectious disease challenges.

𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗔𝗻𝘁𝗶𝗺𝗶𝗰𝗿𝗼𝗯𝗶𝗮𝗹 𝗦𝘂𝘀𝗰𝗲𝗽𝘁𝗶𝗯𝗶𝗹𝗶𝘁𝘆 𝗧𝗲𝘀𝘁 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵

𝗕𝘆 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 :
Kits, Reagents, & Consumables
Automated Test Systems
Culture Media

𝗕𝘆 𝗠𝗲𝘁𝗵𝗼𝗱 :
Broth Dilution Method
Rapid Automated Method
Disk Diffusion Method
Gradient Diffusion Method
Molecular Testing Method

𝗕𝘆 𝗧𝗲𝘀𝘁 𝗧𝘆𝗽𝗲 :
Antibacterial
Anti-parasitic
Antifungal
Others

𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 .
Clinical Diagnosis
Drug Discovery and Development
Others

𝗕𝘆 𝗘𝗻𝗱-𝘂𝘀𝗲𝗿 :
Diagnostic Laboratories and Hospitals
Research and Academic Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations

𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲𝘀

North America (U.S., Canada)
Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
EU - (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
CIS & Russia
Japan
Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)

𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲 𝘁𝗵𝗶𝘀 𝗿𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝘆𝗼𝘂𝗿 𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻:https://www.factmr.com/connectus/sample?flag=RC&rep_id=4334?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.